RE: RE:RE: Crumbs12 May 2019 16:35
Big pharma were and probably still are in a phase where they didn't believe that cancer vaccines was the way to go. As we have seen they have invested huge amounts in CIs, in TCR and in Car-T. Now the tide is possibly turning with more interest in vaccines evidenced by the Genentech/Biontech collaboration and also comments by a Nobel prize winner.
Now moditope is probably unique, certainly in the targets it goes after since Scancell has the patents for these but also for the way it uses CD4 killer cells as its weapon of mass destruction. All Lindy did was identify the targets and design a vaccine that would trigger the immune system to attack those targets. It took her over 30 years to get to this stage so I don't know what she has been playing around at all that time Lol